Korea Arlico PharmLtd Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Korea Arlico PharmLtd.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 33.3% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Korea Arlico PharmLtd (KOSDAQ:260660) Is Carrying A Fair Bit Of Debt
Nov 12There's Reason For Concern Over Korea Arlico Pharm Co.,Ltd.'s (KOSDAQ:260660) Price
Aug 04Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?
Mar 24Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?
Mar 02Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares
Feb 12What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?
Jan 25Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?
Jan 04Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?
Dec 16Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?
Nov 25In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Korea Arlico PharmLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 178,827 | -8,865 | -20,384 | -7,293 | N/A |
3/31/2024 | 183,958 | -1,369 | -15,574 | 2,066 | N/A |
12/31/2023 | 187,155 | 3,061 | -16,372 | 7,148 | N/A |
9/30/2023 | 186,794 | 7,281 | -22,008 | 8,301 | N/A |
6/30/2023 | 184,088 | 9,943 | -22,584 | 6,957 | N/A |
3/31/2023 | 172,363 | 7,701 | -18,810 | 7,131 | N/A |
12/31/2022 | 167,737 | 8,034 | -17,571 | 4,836 | N/A |
9/30/2022 | 162,933 | 8,617 | -11,746 | 2,318 | N/A |
6/30/2022 | 155,676 | 5,807 | -673 | 8,130 | N/A |
3/31/2022 | 151,732 | 5,663 | -2,415 | 6,140 | N/A |
12/31/2021 | 140,157 | 4,930 | 4,052 | 8,967 | N/A |
9/30/2021 | 130,924 | 3,774 | 8,218 | 14,444 | N/A |
6/30/2021 | 127,368 | 6,579 | -3,092 | 7,172 | N/A |
3/31/2021 | 124,436 | 7,387 | -1,863 | 7,524 | N/A |
12/31/2020 | 124,809 | 8,372 | -5,473 | 4,546 | N/A |
9/30/2020 | 126,019 | 10,800 | -4,712 | 3,313 | N/A |
6/30/2020 | 122,859 | 11,050 | 3,795 | 7,184 | N/A |
3/31/2020 | 120,229 | 10,950 | 6,817 | 9,885 | N/A |
12/31/2019 | 115,793 | 10,031 | 10,478 | 13,133 | N/A |
9/30/2019 | 111,609 | 9,573 | 11,400 | 8,751 | N/A |
6/30/2019 | 105,864 | 8,183 | -9,119 | 3,847 | N/A |
3/31/2019 | 100,502 | 6,597 | -18,931 | 413 | N/A |
12/31/2018 | 95,338 | 1,218 | -20,508 | -1,639 | N/A |
9/30/2018 | 87,297 | -1,805 | -25,156 | 784 | N/A |
6/30/2018 | 82,803 | -2,092 | -4,951 | 5,848 | N/A |
3/31/2018 | 77,032 | -1,757 | N/A | 9,880 | N/A |
12/31/2017 | 71,358 | 3,339 | N/A | 9,006 | N/A |
9/30/2017 | 66,342 | 4,062 | N/A | 8,960 | N/A |
6/30/2017 | 60,887 | 4,156 | N/A | 5,116 | N/A |
3/31/2017 | 53,883 | 3,292 | N/A | 3,824 | N/A |
12/31/2016 | 48,127 | 2,243 | N/A | 6,014 | N/A |
12/31/2015 | 32,986 | 624 | N/A | 1,074 | N/A |
12/31/2014 | 29,639 | 501 | N/A | 953 | N/A |
12/31/2013 | 28,730 | 767 | N/A | 1,519 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A260660's forecast earnings growth is above the savings rate (2.7%).
Earnings vs Market: Insufficient data to determine if A260660's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A260660's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A260660's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A260660's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A260660's Return on Equity is forecast to be high in 3 years time